Introduction
Shapiro syndrome is extremely rare with only a few cases in world and first described in the literature in 1969. 1 It is characterized by the triad of spontaneous periodic hypothermia, hyperhidrosis and agenesis of the corpus callosum. 1 The accepted pathophysiological mechanism is the decrease of the 'set point' temperature in the hypothalamus, resulting in neurological and psychological disorders. 2 Although the exact mechanism of this syndrome is unknown, some case reports suggest that attacks can be controlled with clonidine 3 or
Learning points
• Implantable cardioverter defibrillator therapy can be successful in treating ventricular fibrillation (VF) episodes in patients with unexpected periods of hypothermia.
• Ventricular fibrillation in patients with Shapiro syndrome can occur without QT lengthening.
• Patients with hypothermic-related VF are at higher risk of developing VF, and should be monitored carefully. 
Timeline

Case presentation
A 45-year-old man was admitted to our emergency department with an out of hospital cardiac arrest caused by VF. His medical history included Shapiro syndrome with many years of recurrent hospitalizations for hypothermia as low as 32 C, often accompanied by ataxia and/or delirium. In an effort to control his hypothermic episodes he was treated with chlorpromazine. The electrocardiogram (ECG) made by the paramedics on arrival demonstrated VF, which was successfully terminated with three external defibrillator shocks. At return of spontaneous circulation the ECG revealed a sinus bradycardia of 40/min with a normal heart axis, a first-degree AV block and Osborn waves with normal QT interval lengths ( Figure 1) . Physical examination demonstrated a body temperature of 28.7 C. The echocardiography at admission revealed no abnormalities. The cardiac arrest was attributed to VF caused by the hypothermia since other possible causes, such as ischaemia, structural heart diseases, and electrolyte disorders, were excluded. During the warm-up phase at the intensive care unit a 2nd degree AV block Type 2 was documented ( Figure  2 ). After recovery and warming up to the normal temperature of 34 C for the present patient he received a dual chamber ICD for the prevention of sudden cardiac death and for the option of pacing during bradycardia. Within 1 month after hospital discharge the patient experienced two episodes of ventricular tachycardia (VT)/VF. During the first episode antitachycardia pacing during charging was not successful and a high energy shock was delivered ( Figure 3) . Two weeks later a second episode of VT/VF was terminated for which two high energy shocks were necessary ( Figure 4) . Hypothermic attacks returned every few days and during both episodes of VT/VF the patient experienced hypothermia. As a consequence of these and former hypothermia episodes, his neurological state was severely affected resulting in being bedridden.
One year after ICD implantation the patient was admitted for a prolonged period due to recurrent episodes of 'fever'. During the 'fever' his temperature was 37.9 C and assumed extremely elevated for this patient. He was diagnosed with a urinary tract infection which was treated with several antibiotics after which he was discharged. Two weeks after discharge the patient unfortunately passed away. Post-mortem interrogation of the ICD did not disclose any further ventricular arrhythmias. At the time of his death the only finding seen on the ICD was a higher supraventricular heartrate, most likely a sinus tachycardia, although a supraventricular arrhythmia could not be excluded ( Figure 5 ). Given the history of the patient, this was attributed to a recurrent infection. Since no autopsy was performed a definitive diagnosis could not be made. It was concluded that the most likely cause of death was an uncontrolled infection.
Discussion
To the best of our knowledge, this is the first patient with Shapiro syndrome who was successfully treated with an ICD for recurrent VT/VF. The ICD gave us the possibility to assess the cause of death in the present patient. Although the ICD had successfully converted life-threatening arrhythmias before, the final cause of death was not VT/VF. The fact that ventricular arrhythmias are present and can successfully be treated in Shapiro syndrome was not shown before. On forehand it could be debated that ICD therapy without treating the underlying hypothermia would be unsuccessful. With the present case we were able to show that ICD treatment in a malignant hypothermic syndrome was successful in treating the VT/VF episodes, something that was not demonstrated before. Several things can be learned from this case. First, it seems fair to say that VT/VF in patients with Shapiro syndrome can occur without QT lengthening since no QT lengthening was observed directly after resuscitation. Furthermore, the Osborn waves observed after resuscitation reflected the hypothermic state which could be the cause of VF in this patient. Several studies showed an increased risk of VF in hypothermic patients with Osborn waves. 5, 6 A study of Fleming and Muir 6 concluded that the appearance of Osborn waves in hypothermic patients is a forerunner of VF, since five out of six hypothermic patients developed VF within 45 min after the appearance of Osborn waves. However, other reports did not find this association. The prevalence and amplitude of Osborn waves increase with the severity of hypothermia 7 but do not increase the risk of VF. 8 In contrast to the study of Fleming and Muir, several other reports have shown that the incidence of VF in hypothermic patients with Osborn waves is low, ranging from 0% to 2%. [9] [10] [11] Therefore, the correlation between
Osborn waves and the development of VF in hypothermic patients is not clear. However, patients with hypothermic-related Osborn waves are at higher risk of developing VF, and should be monitored 12 In this case, despite the fact that the underlying trigger of the arrhythmias could not be treated, lengthening of life was achieved by successful ICD treatment of the VF episodes. In addition, we were able to demonstrate that the cause of death was not a malignant arrhythmia. 
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Figure 4
Second ventricular tachycardia/ventricular fibrillation episode terminated after the second implantable cardioverter defibrillator shock.
Figure 5
Heart rate in the last months life showing tachycardia in the last days before death.
